A Qiagen therascreen EGFR RGQ PCR kit (ARMS method) has been approved in the United States as well as Europe and Asian countries to detect EGFR mutations with high sensitivity and specificity in lung cancer tissues [13]. Here, EGFR is linked to lung carcinoma.